NASDAQ: NEUPNeuphoria Therapeutics Inc Stock Forecast, Predictions & Price Target
Analyst price target for NEUP
Based on 2 analysts offering 12 month price targets for Neuphoria Therapeutics Inc
Min Forecast
$21.00+61.41%
Avg Forecast
$28.00+115.22%
Max Forecast
$35.00+169.02%
Should I buy or sell NEUP stock?
Based on 2 analysts offering ratings for Neuphoria Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NEUP's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NEUP as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their NEUP stock forecasts and price targets.
NEUP stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| locked | locked | $00.00 | +00.00% | 2025-09-11 | ||
| locked | locked | $00.00 | +00.00% | 2025-08-26 |
Forecast return on equity
Is NEUP forecast to generate an efficient return?
Company
-15.24%
Industry
130.75%
Market
-52.16%
NEUP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast
Forecast return on assets
Is NEUP forecast to generate an efficient return on assets?
Company
-12.9%
Industry
47.72%
NEUP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast
NEUP vs Biotech Stocks
Neuphoria Therapeutics Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.